37 results about "Tracheal bronchus" patented technology

The invention relates to the field of immunological detection, in particular to a pepsase chemiluminescent immunoassay kit and a method thereof. The pepsase chemiluminescent immunoassay kit provided by the invention comprises: 1) a pepsase antigen calibrator; 2) sample collecting solution at a pH value of 2 to 3; 3) sample diluents at a pH value of 6 to 8; 4) a microporous plate coated by a pepsase antibody; 5) a pepsase antibody marker; 6) a chemical luminescence substrate liquid; and 7) concentrated cleaning solution. The kit provided by the invention can detect the pepsase content in gastric juice, esophageal content, throat secretion and tracheal bronchus secretion, judge if gastroesophageal reflux happens according to the result of the pepsase detection and judge the treatment effectof stomach diseases and change of state of illness according to the detected pepsase content. The kit has the advantages of noninvasiveness, simplicity, convenience, quickness, sensitivity, stabilityand the like.

Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.

The invention relates to a dry powder inhalant capable of preventing mycobacterium tuberculosis from transmitting through respiratory tract, and is capable of effectively solving a medical problem that mycobacterium tuberculosis infects pulmonary tuberculosis through the respiratory tract. The method comprises the following steps of: preparing the dry powder inhalant from 9.9-80% of an isoniazide sustained release microsphere, 19.9-90% of a rifampicin sustained release microsphere and 0.1-5% of a flow aid by weight percent, uniformly mixing the isoniazide sustained release microsphere, the rifampicin sustained release microsphere and the flow aid, packaging in gelatin or plastic capsules or aluminum-plastic bubble caps, or packaging in a multi-dosage dry powder inhalation device in the form of a reservoir, so as to obtain the dry powder inhalant. The dry powder inhalant disclosed by the invention is scientific and rational in formula, easy to produce and manufacture, good in use effect, and favorable for the powder to enter into pulmonary alveoli; the medicine is transmitted to and absorbed by the pulmonary alveoli to effectively kill and inhibit mycobacterium tuberculosis in trachea, bronchia and alveoli secretion of the respiratory tract, so as to reduce the quantity of floating droplets of patients of pulmonary tuberculosis removed in the surrounding environment, and to block the transmission of the mycobacterium tuberculosis in the public environment; and therefore, the dry powder inhalant has an important meaning for preventing the pulmonary tuberculosis.

The invention discloses a fiber bronchoscope training box which comprises a box body, wherein the box body comprises an upper closed box body and a lower rectangular box body, the top of the box bodyis provided with a hole, the upper box body is in a tapered shape simulating the human body chest, the lower box body is provided with an opening which is provided with an openable door, a plurality of parallel partition boards are transversely arranged in the upper box body and the lower box body, the partition boards are provided with a plurality of through holes according to the tracheal bronchus structure, and the partition boards are movably or fixedly connected with the side wall of the box body. The invention has simple structure, low manufacture cost, strong operability and easy popularization and application, is scientific and reasonable in design because the through holes are arranged according to the corresponding positions of the tracheal bronchus under a living body fiber bronchoscope, and can achieve the purpose of promoting an operator to skillfully hold the human body tracheal bronchus structure.

The invention belongs to the technical field of food, and particularly relates to an almond tea drink capable of reducing haze harm and a preparing method thereof. The almond tea drink is prepared from dehulled apricot kernel, sticky rice, oat, lily, honeysuckle flower, fructo-oligosaccharide, tremella, dried rhizoma dioscoreae, licorice root, xylitol, stabilizer and water, raw material selection, baking and smashing, rehydration superfine grinding, blending and volume determination are conducted, the product is sent to a blending tank through a colloid mill, water is added into the blending tank, then homogenizing is conducted, homogenized drink pulp is sterilized through an ultra high temperature short time sterilization machine and cooled, and then filling is conducted. The almond tea drink has a long shelf life, is convenient to carry and can be drunk immediately after being opened. Although the almond tea drink can not directly act on haze particles, the almond tea drink can foster root and strengthen qi and can reduce the harm to lung by enhancing the immunity of lung; the formation of a mucous blanket on the tracheal epithelium is helped, and particle absorption and interception capacity is improved; tracheal bronchus cilium motility is improved, filtration and discharge of particles are helped, and then haze harm is reduced.

Research finds that exocrine protein SCGB3A2 in lung tracheal bronchus is combined with a receptor PDPN on the cell surface and activates RhoA protein, so that the strength of pneumonia and the expression quantity of inflammatory factors are enhanced, and lung inflammation can be relieved and expression of inflammatory factors and infiltration of lung inflammatory cells can be reduced by blocking combination of SCGB3A2 and PDPN through an antibody. Therefore, the invention provides a brand new target for controlling lung inflammatory factor storm caused by bacteria or viruses. The target spot has a relatively clear signal transmission path, so that the side effect of the medicine for inhibiting the inflammatory factor storm, which is prepared aiming at the target spot, is smaller than that of glucocorticoid.

The invention relates to an oral tablet and a preparation method thereof. The oral tablet is mainly prepared from the following raw materials in parts by weight: 2-4 parts of coptis root leaf, 1-3 parts of honeysuckle, 1-3 parts of licorice, 1-3 parts of radix platycodi and 0.5-2 parts of peppermint. The oral tablet has good mouth feel and unique taste (a person feels sweet when the oral tablet enters the mouth, the person can feel both sweet taste and bitter taste after the oral tablet enters the mouth, weaker bitter taste still exists in the oral cavity even after the oral tablet is completely dissolved, and the person also feels coarse, fresh and cool when the oral tablet enters the mouth) and the oral tablet can be eaten as candy. Because of addition of the traditional Chinese medicines of the coptis root leaf and the like, the oral tablet has an obvious effect for ulceratiue stomatitis and throat gall which are caused by suffering from excessive internal heat and is combined withthe honeysuckle with the function of clearing away heat and toxic materials, the peppermint with the functions of dispelling wind heat and relieving sore-throat, the radix platycodi with the functions of promoting the dispersing function of the lung, relieving sore-throat and benefiting the voice and the licorice with the function of protecting the throat and the tracheal bronchus; the five medicines all serve as the raw materials, which can truly achieve the therapeutic effects of clearing and benefiting the throat.

The invention discloses a thymus mongolicus essential oil soft capsule for treating bronchitis and a therapy of the thymus mongolicus essential oil soft capsule. Thymus mongolicus essential oil has relatively strong effects of inhibiting bacteria, resisting viruses, resisting inflammation, resisting allergy, relieving cough, reducing sputum and the like. According to the invention, the thymus mongolicus essential oil is used as a medicinal component to prepare the soft capsule, an electronic heater is used as an administration tool, a mechanical structure of the heater is used to damage the soft capsule, contained essential oil is slowly released, medicine molecules in the essential oil are vaporized in an electric heating manner, and the medicine molecules are inhaled into respiratory tracts through mouths and noses, so that the medicine molecules can deeply and directly reach lesion parts such as tracheas and bronchus to quickly play roles. As a directional administration mode, thetherapy has the advantages of obvious quick-acting effect and positioning effect, local administration, quick effect, small dosage and small toxic and side effects, has obvious curative effects on bronchitis treatment, cough relieving and sputum reduction, and can be used as an effective antibiotic replacement and antibiotic reduction treatment means.

The invention discloses a video tracheobronchial foreign body microscopic examination general anesthesia system. In the system, a microscopic examination anesthesia ventilation laryngotracheal microscope is a three-way special-shaped tube (1-5); the front end of the three-way special-shaped tube (1-5) serves as a video end outlet (1-6); an installation sliding telescopic tube (1-3) and a pipeline of a tracheobronchial microscope are arranged in the three-way special-shaped tube (1-5); and the outer side of one circle of the pipeline (1-1) is provided with a breathing air duct (2-10). According to the invention, an anesthesia breathing ventilation structure used for video anesthesia and extraction of microscopic examination foreign bodies, microscopic examination software programming and automatic storage and output of microscopic examination results are realized; a similar equipment system does not exist at home and abroad, and improved ventilation for an infant intratracheal foreign body microscope and general anesthesia are reported but are not perfect and reliable; and a microscopic examination anesthesia system for increasing the infant intratracheal foreign body curing rate and the survival rate, reducing damage caused by accidental suction of infants and improving the survival quality is needed.

The invention relates to the field of immunological detection, in particular to a pepsase chemiluminescent immunoassay kit and a method thereof. The pepsase chemiluminescent immunoassay kit provided by the invention comprises: 1) a pepsase antigen calibrator; 2) sample collecting solution at a pH value of 2 to 3; 3) sample diluents at a pH value of 6 to 8; 4) a microporous plate coated by a pepsase antibody; 5) a pepsase antibody marker; 6) a chemical luminescence substrate liquid; and 7) concentrated cleaning solution. The kit provided by the invention can detect the pepsase content in gastric juice, esophageal content, throat secretion and tracheal bronchus secretion, judge if gastroesophageal reflux happens according to the result of the pepsase detection and judge the treatment effect of stomach diseases and change of state of illness according to the detected pepsase content. The kit has the advantages of noninvasiveness, simplicity, convenience, quickness, sensitivity, stability and the like.

Disclosed is a device for stimulating the tracheobronchial air of a patient suffering from an obstructive ventilatory disorder and able to modify the rheology of his tracheobronchial mucus, which includes a negative pressure generator, a physiological interface able to interface the device with the patient's respiratory apparatus, a connection pipe connecting the physiological interface to the negative pressure generator, and a control circuit capable of controlling the negative pressure generator, during the passive expiration phase, for the application of a succession of alternation of negative pressure and venting impulses with a determined frequency and a duty cycle determined during a first part of an expiration cycle and then a second frequency and a second duty cycle during a second part of the expiration cycle and to reiterate a defined number of expiration cycles.

The invention relates to a dry powder inhaler capable of preventing respiratory transmission of Mycobacterium tuberculosis, which can effectively solve the drug problem of preventing and treating tuberculosis infection by Mycobacterium tuberculosis through the respiratory tract. %, rifampicin sustained-release microspheres 19.9-90%, glidant 0.1-5%, first mix isoniazid sustained-release microspheres, rifampicin sustained-release microspheres, and glidants together, Packed in gelatin, plastic capsules or aluminum-plastic blisters, or packaged in a multi-dose dry powder inhalation device in the form of a reservoir; the composition of the present invention is scientific, reasonable, easy to manufacture, good in use effect, and beneficial to powder The body enters the alveoli, and the drug is delivered to the alveoli to be absorbed. It is effectively used to kill and inhibit the Mycobacterium tuberculosis in the trachea, bronchi and alveolar secretions in the respiratory tract, and reduce the number of droplets with floating ability that tuberculosis patients exclude into the surrounding environment. To block the spread of Mycobacterium tuberculosis in the public environment is of great significance to the prevention of tuberculosis.

The invention provides cakes capable of eliminating phlegm and stopping a cough and a making method of the cakes. The cakes capable of eliminating phlegm and stopping a cough comprise the following components by mass of 4-15 grams of rhizoma pinelliae preparata, 6-15 grams of fried sweet almonds, 4-12 grams of candied common coltsfoot flowers, 10-22 grams of rhizoma polygonati, 8-18 grams of radixasparagi, 4-15 grams of rhizoma polygonati odorati, 4-14 grams of dried orange peel, 8-16 grams of stir-baked snakegourd seeds, 12-20 grams of radix codonopsis, 8-16 grams of radix astragali preparata, 10-22 grams of platycodon roots, 4-8 grams of herba ephedrae preparata and 100-250 grams of parched rice. The traditional Chinese medicines and the like are prepared, so that the cake-shaped food materials having efficacy of moistening the lung for removing phlegm and relieving cough and asthma can be made. Because attack parts of cough, expectoration and phlegm dyspnea are mostly focused on the trachea, the bronchus, the lung and the chest cavity of upper organs of human bodies, patients can directly eat the cakes, when the cakes are chewed repeatedly by teeth, the drug properties can directly enter the disease focus position, the diffusing area is large, the release speed is high, and the cakes are convenient to absorb and digest by human bodies. The drug effect is increased, and thecakes have great help for assisting in treatment of respiratory system diseases and relevant symptoms.